Provided by Tiger Trade Technology Pte. Ltd.

Sera Prognostics, Inc.

2.52
+0.20008.62%
Post-market: 2.520.00000.00%16:04 EST
Volume:28.73K
Turnover:73.39K
Market Cap:97.26M
PE:-3.37
High:2.68
Open:2.35
Low:2.35
Close:2.32
52wk High:4.85
52wk Low:1.37
Shares:38.59M
Float Shares:24.40M
Volume Ratio:0.91
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7475
EPS(LYR):-0.9922
ROE:-47.69%
ROA:-24.70%
PB:1.18
PE(LYR):-2.54

Loading ...

Sera Prognostics CIO Robert Gardner Reports Disposal of Common Shares

Reuters
·
Jan 28

Sera Prognostics Unveils Strategy to Redefine Pregnancy Care

TIPRANKS
·
Jan 09

Sera Prognostics Study Finds PreTRM Blood Test Reduces Preterm Births and Newborn Complications

Reuters
·
Jan 07

Sera Prognostics Inc. Chief Information Officer Robert Gardner Reports Disposal of Common Shares

Reuters
·
Dec 31, 2025

Social Enterprise Research Academy conducted "2025 ESG Leader Summit -Tech for Good"& Signed MOU with CIAPST to facilitate Cooperation between Mainland China and Hong Kong Uniting Forces from All Sectors for Collaboration

prnewswire
·
Dec 22, 2025

Jefferies Initiates Sera Prognostics With Buy Rating, $5 Price Target

MT Newswires Live
·
Dec 15, 2025

U.S. RESEARCH ROUNDUP-Applied Materials, Coca-Cola, Glacier Bancorp

Reuters
·
Dec 15, 2025

Chief Data Officer Paul Kearney Sells Sera Prognostics Inc. Common Shares

Reuters
·
Dec 12, 2025

Chief Scientific Officer John J. Boniface Reports Sale of Sera Prognostics Inc. Common Shares

Reuters
·
Dec 12, 2025

Sera Prognostics CEO Zhenya Lindgardt Reports Sale of Common Shares

Reuters
·
Dec 11, 2025

Director Mirza Mansoor Raza Disposes of Sera Prognostics Inc. Common Shares

Reuters
·
Dec 06, 2025

Chief Data Officer Paul Kearney Reports Sale of Sera Prognostics Common Shares

Reuters
·
Dec 04, 2025

Chief Data Officer Paul Kearney Sells Sera Prognostics Inc. Common Shares

Reuters
·
Nov 27, 2025

Sera Prognostics’ PRIME Study Accepted for Publication

TIPRANKS
·
Nov 25, 2025

Sera Prognostics Announces Publication Acceptance of PRIME Study on Preterm Birth

Reuters
·
Nov 24, 2025

Sera Prognostics Q3 Income From Operations USD -8.98 Million

Reuters
·
Nov 20, 2025

Sera Prognostics: Strategic Growth and Market Penetration Justify Buy Rating

TIPRANKS
·
Nov 15, 2025

Analysts’ Top Healthcare Picks: Acrivon Therapeutics, Inc. (ACRV), Sera Prognostics (SERA)

TIPRANKS
·
Nov 14, 2025

Sera Prognostics Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 14, 2025

Sera Prognostics Q3 EPS $(0.16) Beats $(0.22) Estimate, Sales $16.000K Miss $85.000K Estimate

Benzinga
·
Nov 14, 2025